chr10-74095751-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_014000.3(VCL):c.1639C>T(p.Arg547*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014000.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251448Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135898
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Uncertain:1
The p.Arg547X variant in VCL has been identified in 1 infant with dilated cardiomyopathy (DCM; Hawley 2020 PMID: 32516855, LMM data). It was absent from large population studies (gnomAD, v.3.1.2). This nonsense variant leads to a premature termination codon at position 547, which is predicted to lead to a truncated or absent protein. Mouse models have shown that loss of function of the VCL gene can lead to DCM (Zemljic-Harpf 2007 PMID: 17785437), although the mode of inheritance associated with such variants in humans is not yet clear. Heterozygous loss-of-function variants in VCL have been identified in several individuals in our laboratory, many of whom had early onset DCM; however, these variants have also been identified in unaffected family members and family members with later onset disease (Hawley 2020 PMID: 32516855). In summary, although there is some evidence suggesting an association between truncating variants in VCL and DCM, there is not currently enough information to determine the strength of this association or to clearly delineate a mode of inheritance. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting. -
Cardiovascular phenotype Uncertain:1
The p.R547* variant (also known as c.1639C>T), located in coding exon 12 of the VCL gene, results from a C to T substitution at nucleotide position 1639. This changes the amino acid from an arginine to a stop codon within coding exon 12. This alteration is expected to result in protein truncation or nonsense-mediated mRNA decay. However, loss of function of VCL has not been established as a mechanism of disease. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at